Literature DB >> 33048125

In Support of CDK4/6 Inhibitors-A Meta-analysis of Available Randomized Data.

James M Martin1, Lori J Goldstein2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33048125     DOI： 10.1001/jamanetworkopen.2020.21062

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  3 in total

1.  Error in Author Affiliation.

Authors: 
Journal:  JAMA Netw Open       Date:  2020-11-02

2.  Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study.

Authors:  Judith J Stephenson; Jonathon Colby Gable; Rebekah Zincavage; Gregory L Price; Collin Churchill; Emily Zhu; Keri Stenger; Mukul Singhal; Bal Nepal; Michael Grabner; Michael J Fisch; David Debono; Amy R Geschwender; Gebra Cuyun Carter
Journal:  Patient Prefer Adherence       Date:  2021-11-03       Impact factor: 2.711

3.  Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial.

Authors:  Katya Galactionova; Sibylle Loibl; Paola Salari; Frederik Marmé; Miguel Martin; Michael Untch; Hervé R Bonnefoi; Sung-Bae Kim; Harry D Bear; Nicole McCarthy; Karen A Gelmon; José A García-Sáenz; Catherine M Kelly; Toralf Reimer; Masakazu Toi; Hope S Rugo; Michael Gnant; Andreas Makris; Nicole Burchardi; Matthias Schwenkglenks
Journal:  Front Oncol       Date:  2022-09-05       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.